Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KraneShares Electric Vehicles and Future Mobility (KARS) vs Revvity Inc (RVTY) Price & Performance

KraneShares Electric Vehicles and Future MobilityTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

KraneShares Electric Vehicles and Future Mobility vs Revvity Inc — how do they compare? KraneShares Electric Vehicles and Future Mobility trades at $30.53, while Revvity Inc trades at $115.76 (market cap $12.94B). The key difference: Revvity Inc pays a 0.24% dividend while KraneShares Electric Vehicles and Future Mobility pays none, and Revvity Inc is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.

KARSRVTY
Sector
Sector/ThematicTechnology
52-Week High
$38.01$117.75
52-Week Low
$25.59$82.26
Market Cap
$12.94B
Enterprise Value
$15.26B
Dividend Yield
0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KraneShares Electric Vehicles and Future Mobility

KARS trades at $30.86, up 2.51% today, with a bullish technical signal but bearish moving averages. Recent news highlights global EV sales growth, particularly in Europe and China, though U.S. adoption lags. The stock shows strong momentum with RSI_6 at 80.23 indicating overbought conditions, while support and resistance cluster around $30-$31.

The outlook for KARS is mixed; positive EV industry trends support growth, but high RSI suggests near-term pullback risk. Investment opportunity lies in global EV expansion, while risks include U.S. market hesitation and competitive pressures from Chinese automakers.

Revvity Inc

RVTY trades at $114.66, up 0.37% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a 54.98% gross margin and $241.20M net income for 2025, supported by positive news including product launches and raised 2026 guidance. Analyst consensus is a buy with a $120.50 price target, indicating potential upside from current levels.

Outlook remains positive due to consistent earnings outperformance and innovation in diagnostics, but risks include high P/E valuation and competitive pressures. Investors may find opportunity in sustained margin strength and AI integration, though macroeconomic sensitivity warrants caution.

Returns comparison

Trailing returns across standard periods

About KraneShares Electric Vehicles and Future Mobility

KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.

Read more on KARS

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY